Ocrelizumab significantly reduced the number and volume of cortical lesions associated with multiple sclerosis at 120 weeks, ...
Current conventional imaging will continue to impact our ... Relapsing–remitting multiple sclerosis. BPF: Brain parenchymal fraction; CIS: Clinically isolated syndrome; CTh: Cortical thickness ...